ArticlePharmacoEconomics2021

Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden.

Ronan Mahon et al.PubMed ↗Publisher ↗

No numbers read from the abstract.